Zevra Therapeutics
Stacy Hoffmann is an accomplished professional in the pharmaceutical and biotech industry, currently serving as Executive Director of Commercial Effectiveness at Zevra Therapeutics since November 2023. Previously, Stacy held the position of Senior Director of Commercial Operations and Excellence at Fennec Pharmaceuticals Inc from May 2022 to September 2023. Prior experience includes roles such as Head of Field Training and Market Operations Effectiveness at Orphazyme, Sr. Director Training and Development, and Director of Training and Development at AveXis, Inc. From July 2012 to November 2018, Stacy worked at Lundbeck, progressing through positions including Director Commercial Operations and Associate Director of Marketing Operations. Earlier in the career, Stacy gained valuable experience as Sr. Manager of Marketing Operations Approval Process at Takeda Pharmaceuticals from 2000 to 2010. Stacy holds a Bachelor of Science degree from Elmhurst University.
This person is not in any teams
This person is not in any offices
Zevra Therapeutics
1 followers
We are a rare disease therapeutics company leading with science to make life-changing therapeutics available to patients with significant unmet needs. We involve key thought leaders, physicians, patients, care partners, and advocacy groups in all of our clinical and regulatory development strategies. With a keen understanding that drug development often requires creative solutions, we have the insight and expertise to forge new pathways to success that others have missed. By following the data without bias, our transparent narratives and common-sense perspective have successfully overcome complex development challenges to make much-needed therapies available to patients. Nimble and dauntless, we push boundaries beyond what is thought to be possible and advance new therapies that have the potential to bring meaningful improvement to patients’ lives.